ArticleInvestigative ophthalmology & visual science2026
High-Resolution OCT Profiling of Bruch's Membrane in Extensive Macular Atrophy With Pseudodrusen-Like Appearance and Geographic Atrophy.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To characterize Bruch's membrane breaks (BMBs) in extensive macular atrophy with a pseudodrusen-like appearance (EMAP) and geographic atrophy (GA) and to explore their associations with microstructural features within the bed of atrophy, such as basal laminar deposit (BLamD) debris and hyperreflective pyramidal structures (HPSs). Methods: High-resolution optical coherence tomography volumes were obtained from 44 eyes. Quantitative metrics included scan length within atrophy, total BMB length, BMB density per B-scan, and BMB density normalized by atrophy area. Colocalization with microstructural features was assessed per B-scan based on spatial overlap. Results: Patients with GA were significantly older than those with EMAP (80.86 ± 4.75 vs. 61.35 ± 2.62 years; P < 0.001). The atrophy area was larger in EMAP (20.63 ± 14.55 mm²) than GA (7.92 ± 7.27 mm²; P = 0.001). EMAP exhibited a longer BMB length (227.73 ± 311.92 µm vs. 78.00 ± 51.37 µm; P < 0.001) but a lower BMB density per B-scan (1.78 ± 2.43 vs. 5.73 ± 6.75; P < 0.001). Associated features were found in 64.3% of BMBs, more frequently in GA (86.2%) than in EMAP (59.2%; P = 0.006). BLamD debris predominated in EMAP (51.4%), whereas HPS predominated in GA (91%). Conclusions: BMBs associated with EMAP are more likely to be found in widespread BLamD debris areas, while GA shows focal, calcified defects associated with HPS. These findings suggest distinct pathways of BM failure, diffuse in EMAP and focal and mechanical in GA. The clinical implications of these differences and their impact on atrophy progression warrant further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.